G
Gaudium IVF and Women Health Ltd
GAUDIUMIVF NSE
Gaudium IVF and Women Health Ltd
HealthcareNSE: GAUDIUMIVF BSE: 544709 Healthcare Services
Key Fundamentals
MicrocapHealthcare Service ProviderHealthcareMarket Cap
₹973 Cr
Volatility
Moderate
P/E Ratio
30.31
EBITDA
₹37.71 Cr
Return on Equity
41.31%
Debt to Equity
0.16
Book Value
₹20.92
52W High
₹163.18
52W Low
₹69.18
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Gaudium IVF and Women Health Ltd insights
39 extracted metrics + investor summaries across FY22–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
1- Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 187 days.
- Working capital days have increased from 39.9 days to 90.9 days
Growth Rate
Revenue Growth
46.99% ↗
Net Income Growth
28.06% ↘
Cash Flow Change
153.49% ↗
ROE
-17.21% ↘
ROCE
-15.64% ↘
EBITDA Margin (Avg.)
-11.61% ↘
Quarterly Results
| Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 14.42 | 26.92 | 31.73 | 24.51 | 30.35 |
| Expenses | 8.76 | 18.2 | 17.96 | 17.95 | 18.18 |
| Operating Profit | 5.66 | 8.72 | 13.77 | 6.56 | 12.17 |
| OPM % | 39.25% | 32.39% | 43.4% | 26.76% | 40.1% |
| Other Income | 0 | 0.23 | 0.15 | 0.1 | 0.18 |
| Interest | 0.39 | 0.43 | 0.51 | 1.2 | 1.29 |
| Depreciation | 0.58 | 0.36 | 0.61 | 0.49 | 0.64 |
| PBT | 4.69 | 8.16 | 12.8 | 4.97 | 10.42 |
| Tax % | 27.72% | 20.96% | 26.64% | 26.96% | 19.77% |
| Net Profit | 3.4 | 6.46 | 9.38 | 3.63 | 8.36 |
| EPS in Rs | 0.55 | 1.05 | 1.53 | 0.59 | 1.15 |
Profit & Loss
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 37 | 44 | 48 | 71 | 104 |
| Expenses | 23 | 24 | 28 | 42 | 67 |
| Operating Profit | 14 | 20 | 19 | 29 | 38 |
| OPM % | 37% | 46% | 41% | 41% | 36% |
| Other Income | 0 | 0 | 0 | 0 | 1 |
| Interest | 1 | 0 | 1 | 2 | 3 |
| Depreciation | 1 | 1 | 2 | 2 | 3 |
| PBT | 12 | 18 | 17 | 25 | 32 |
| Tax % | 26% | 26% | 38% | 25% | 24% |
| Net Profit | 9 | 14 | 10 | 19 | 24 |
| EPS in Rs | 89.17 | 137 | 104 | 3.12 | 3.36 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.99 | 0.99 | 0.99 | 31 | 36 |
| Reserves | 8 | 22 | 26 | 16 | 116 |
| Borrowings | 6 | 12 | 17 | 21 | 25 |
| Other Liabilities | 3 | 2 | 7 | 22 | 16 |
| Total Liabilities | 18 | 37 | 51 | 89 | 193 |
| Fixed Assets | 4 | 18 | 19 | 18 | 30 |
| CWIP | 0 | 0 | 0 | 7 | 0 |
| Investments | 0 | 0 | 0 | 5 | 5 |
| Other Assets | 14 | 18 | 32 | 58 | 158 |
| Total Assets | 18 | 37 | 51 | 89 | 193 |
Cash Flow
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Operating | -1 | 24 | 3 | 9 | 7 |
| Investing | -1 | -16 | -5 | -15 | -88 |
| Financing | 3 | 5 | -1 | 2 | 82 |
| Net Cash Flow | 0 | 13 | -3 | -5 | 2 |
| Free Cash Flow | -2 | 9 | 1 | 0 | 5 |
| CFO/OP | 13 | 141 | 27 | 46 | 51 |
Ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 65 | 8 | 104 | 170 | 187 |
| Inventory Days | 29 | 111 | 168 | 175 | 38 |
| Days Payable | 114 | 77 | 62 | 338 | 133 |
| Cash Conversion Cycle | -20 | 41 | 210 | 7 | 92 |
| Working Capital Days | 61 | -52 | -15 | 44 | 91 |
| ROCE % | — | 76% | 45% | 49% | 29% |
Documents
1
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026.
7 Aug - Board meeting on August 13, 2026 to approve Q1 FY2027 results; trading window closed until 48 hours post-results. 7 Aug - Board meeting on August 13, 2026 to approve Q1 FY2027 results; trading window closed until 48 hours post-results.
2
Clarification On Price Movement
16 Apr - Company clarified price movement was market-driven and disclosed no new price-sensitive information. 16 Apr - Company clarified price movement was market-driven and disclosed no new price-sensitive information.
3
Intimation Regarding Change Of Corporate Identification Number Of The Company
15 Apr - Company CIN changed to L85100DL2015PLC278296; status updated from unlisted to listed. 15 Apr - Company CIN changed to L85100DL2015PLC278296; status updated from unlisted to listed.
4
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
10 Apr - Compliance certificate under Regulation 74(5) for quarter ended March 31, 2026; no rematerialisation requests. 10 Apr - Compliance certificate under Regulation 74(5) for quarter ended March 31, 2026; no rematerialisation requests.
Frequently Asked Questions about Gaudium IVF and Women Health Ltd
What does Gaudium IVF and Women Health Ltd do?
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]
Where is Gaudium IVF and Women Health Ltd (GAUDIUMIVF) listed?
Gaudium IVF and Women Health Ltd is listed on the Indian stock exchanges. It is listed on NSE: GAUDIUMIVF and BSE: 544709. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Gaudium IVF and Women Health Ltd belong to?
Gaudium IVF and Women Health Ltd operates in the Healthcare sector within the Healthcare Services industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd has a market capitalisation of approximately ₹972.58 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Gaudium IVF and Women Health Ltd?
The Price-to-Earnings (PE) ratio of Gaudium IVF and Women Health Ltd is 30.31. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Gaudium IVF and Women Health Ltd?
Over the past 52 weeks, Gaudium IVF and Women Health Ltd has traded between a low of ₹69.18 and a high of ₹163.18. This range helps investors understand the stock's price volatility and recent trading levels.
What is the Return on Equity (ROE) of Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd has a Return on Equity (ROE) of 41.31%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Gaudium IVF and Women Health Ltd on Tapetide?
On Tapetide, you can view Gaudium IVF and Women Health Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]
Website gaudiumivfcentre.com
Face Value ₹ 5